Online 16th Annual Blood and Marrow Transplant Nursing Forum: Hypertension through Oncology Therapy 8.30.2024

Thursday, September 12, 2024, 3:54 PM - Saturday, September 12, 2026, 4:54 PM

Join us in Sabin Auditorium for our annual forum that presents current issues and innovations affecting the care of bone and marrow transplant patients. Topics include:

• Transpire/BO/Lung Disease
• Research
• HLH Pathology
• Nephrology
• Donor Search
• Patient/Family experiences 

Financial Disclosures:

The following relevant financial relationships have been disclosed: 

Ashley Teusink-Cross, PharmD (Planner) – Honoraria - Jazz Pharmaceuticals; Ashish Kumar, MD (Speaker) – Advisor - Sobi, Advisor - OPNA (relationship has ended); Stefanie Benoit, MD (Speaker) – Advisor - Novartis; Kas Myers, MD (Speaker) – Grant/Research Support - Incyte, Independent Contractor - Elixirgen; Christopher Dandoy, MD (Speaker) - Honoraria - Alexion.

*All relevant financial relationships listed for these individuals have been mitigated. Remaining persons in control of content have no relevant financial relationships.

In support of improving patient care, Cincinnati Children’s Hospital Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing: This activity is approved for continuing nursing education (CNE) contact hours.

 

General Attendance (1.00 hours), Nursing CE (1.00 hours)

Mitigation of Relevant Financial Relationships

Cincinnati Childrens Hospital Medical Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.